A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Toxoplasmosis, CerebralHIV Infections
Interventions
DRUG

Atovaquone

Trial Locations (22)

10003

Beth Israel Med Ctr, New York

10011

Saint Vincent's Hosp and Med Ctr, New York

10037

Harlem Hosp Ctr, New York

20007

Georgetown Univ Med Ctr, Washington D.C.

21205

Johns Hopkins Hosp, Baltimore

22203

Infectious Disease Physicians Inc, Annandale

27710

Duke Univ Med Ctr, Durham

30345

Infectious Disease Research Consortium of Georgia, Atlanta

38103

Regional Med Ctr at Memphis, Memphis

77004

Gathe, Joseph, M.D., Houston

77030

Baylor College of Medicine, Houston

90033

Los Angeles County - USC Med Ctr, Los Angeles

94110

UCSF - San Francisco Gen Hosp, San Francisco

94114

Davies Med Ctr, San Francisco

94609

Infectious Disease Med Group, Oakland

97210

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

117948153

SUNY / Health Sciences Ctr at Stony Brook, Stony Brook

941102859

San Francisco Gen Hosp, San Francisco

Unknown

Southern Alberta HIV Clinic / Foothills Hosp, Calgary

Dr Julio S G Montaner, Vancouver

Wellesley Hosp, Toronto

Dr Emil Toma / Hotel Dieu de Montreal, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY